Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Castera

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.
The Lancet. Gastroenterology & Hepatology|March 26, 2026
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysisZobair M Younossi, Aleksander Krag, Shira Zelber-Sagi, et al.
Human Mutation|October 23, 2022
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicingRaphaël Leman, Béatrice Parfait, Dominique Vidaud, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
Hepatology (Baltimore, Md.)|July 2, 2024
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorderLucile Moga, Valérie Paradis, Joel Ferreira-Silva, et al.
Gut|January 22, 2021
Two-dimensional shear wave elastography predicts survival in advanced chronic liver diseaseJonel Trebicka, Wenyi Gu, Victor de Ledinghen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
BMC Public Health|May 22, 2023
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countriesIsabel Graupera, Maja Thiele, Ann T Ma, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.
The Lancet. Gastroenterology & Hepatology|March 26, 2026
Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysisZobair M Younossi, Aleksander Krag, Shira Zelber-Sagi, et al.
Human Mutation|October 23, 2022
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicingRaphaël Leman, Béatrice Parfait, Dominique Vidaud, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
Nature Reviews. Gastroenterology & Hepatology|October 28, 2021
Advancing the global public health agenda for NAFLD: a consensus statementJeffrey V Lazarus, Henry E Mark, Quentin M Anstee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 5, 2022
Securing wider EU commitment to the elimination of hepatitis C virusHeiner Wedemeyer, Tammo L Tergast, Jeffrey V Lazarus, et al.
Hepatology (Baltimore, Md.)|July 2, 2024
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorderLucile Moga, Valérie Paradis, Joel Ferreira-Silva, et al.
Gut|January 22, 2021
Two-dimensional shear wave elastography predicts survival in advanced chronic liver diseaseJonel Trebicka, Wenyi Gu, Victor de Ledinghen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine CountriesZobair M Younossi, James M Paik, Jeffrey V Lazarus, et al.
BMC Public Health|May 22, 2023
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countriesIsabel Graupera, Maja Thiele, Ann T Ma, et al.
Pageof 21